1. Academic Validation
  2. Structure-activity relationship studies of novel pyrazole and imidazole carboxamides as cannabinoid-1 (CB1) antagonists

Structure-activity relationship studies of novel pyrazole and imidazole carboxamides as cannabinoid-1 (CB1) antagonists

  • Bioorg Med Chem Lett. 2011 Aug 15;21(16):4913-8. doi: 10.1016/j.bmcl.2011.06.017.
Pradip K Sasmal 1 Rashmi Talwar J Swetha D Balasubrahmanyam B Venkatesham Khaji Abdul Rawoof B Neelima Devi Vikram P Jadhav Sanjoy K Khan Priya Mohan D Srinivasa Reddy Vijay Kumar Nyavanandi Srinivas Nanduri Shiva K Kyasa M Kannan P Srinivas Prabhakar Nadipalli Hira Chaudhury V J Sebastian
Affiliations

Affiliation

  • 1 Discovery Research, Dr. Reddy's Laboratories Ltd, Bollaram Road, Miyapur, Hyderabad 500049, India. sasmalpk@yahoo.co.in
Abstract

The synthesis and biological evaluation of novel pyrazole and imidazole carboxamides as CB1 antagonists are described. As a part of eastern amide SAR, various chemically diverse motifs were introduced on rimonabant template. The central pyrazole core was also replaced with its conformationally constrained motif and imidazole moieties. In general, a range of modifications were well tolerated. Several molecules with low- and sub-nanomolar potencies were identified as potent CB1 receptor antagonists. The in vivo proof of principle for weight loss is demonstrated with a lead compound in DIO mice model.

Figures
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》